Centers must complete the Form 2006 for each product when the recipient is assigned to the Comprehensive Report Form track. Centers must also complete the Form 2006 for the following product types when the recipient is assigned to the Transplant Essential Data track:
- NMDP donor products
- NMDP and non-NMDP cord blood units
Additionally, all transplant centers (TED-only and Comprehensive Report Form) participating in the Related Sample Repository must complete the Form 2006 for all non-NMDP donor products when a research sample is collected.
For more information see General Instructions, Center Type and Data Collection Forms.
The Form 2006 is designed to capture product- and infusion-specific information for all pTroducts given to a recipient as part of a Hematopoietic Stem Cell Transplant (HCT). This includes cells given prior to the HCT for reasons other than engraftment. In addition to use in research, this information is used for quality assurance measures, both by the NMDP and the Cord Blood Banks.
If more than one type of HCT product is infused, each product type must be analyzed and reported on a separate form. Two different products from the same donor (for example, PBSC and bone marrow), require two 2006 forms; one for each product.
However, a series of collections from the same donor that uses the same collection method and mobilization cycle, even if the collections are performed on different days, should be considered a single product.
Q1-3: Pre-Collection Therapy
Q4-7: Product Collection
Q8-21: Product Transport and Receipt
Q22-40: Product Processing/Manipulation
Q41-93: Product Analysis
Q94-143: Product Infusion
Q144-170: Donor/Infant Demographic Information
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.
|8/21/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Modify|| Updated the following note box (above Q159) to clarify the intent of Q159-170:
The following questions (
|6/3/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Added||Provided clarification to questions 1, 4, and 5 that these questions are only enabled for PBSC and bone marrow products from non-NMDP donors.|
|5/19/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Modify||For question 13, specified that a constant temperature is usually found in cord blood shipping containers.|
|4/6/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Modify||In section Q144-170: Donor/Infant Demographic Information, moved question 147 to question 159.|
|3/23/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Modify||Added guidance to questions 46 – 47, 58-59, 64-65, 70-71, and 76-77 regarding scenarios where center’s laboratory assay only measures viable cells.|
|2/27/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Modify|| Updated the text for questions 163-165 as indicated below (removed text is struck out and added text is in red):
|1/24/2020||2006: Hematopoietic Stem Cell Transplant (HCT) Infusion||Modify||Version 4 of the 2006: Hematopoietic Stem Cell Transplant (HCT) Infusion section of the Forms Instruction Manual released. Version 4 corresponds to revision 5 of the Form 2006.|
Need more help with this?
Don’t hesitate to contact us here.